Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Augmentation of Lamotrigine in Bipolar Depression
NCT00305578Phase 4Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Aug 2005
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) comparing Memantine with Placebo (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 8 weeks. Started Aug 2005; status: completed.
02
Drugs
memantine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00305578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305578.